Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$655M |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$383M |
| 3 |
Coca-Cola
KO
|
+$367M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$347M |
| 5 |
Salesforce
CRM
|
+$328M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spotify
SPOT
|
+$314M |
| 2 |
CME Group
CME
|
+$263M |
| 3 |
Adobe
ADBE
|
+$232M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$220M |
| 5 |
Northrop Grumman
NOC
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.32% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Financials | 8.41% |
| 4 | Industrials | 8.19% |
| 5 | Healthcare | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Algoma Steel
ASTL
$424M
| $176K | ﹤0.01% |
17,999
-30,646
| -63% | -$316K |
|
2527
Zentalis Pharmaceuticals
ZNTL
$356M
| $175K | ﹤0.01% |
57,592
-11,070
| -16% | -$36.3K |
|
|
CD
2528
Chaince Digital Holdings
CD
$378M
| $174K | ﹤0.01% |
+25,507
| New | +$99K |
|
2529
Horizon Technology Finance
HRZN
$326M
| $173K | ﹤0.01% |
+19,189
| New | +$184K |
|
2530
Lands' End
LE
$377M
| $172K | ﹤0.01% |
+13,107
| New | +$206K |
|
2531
Rezolute
RZLT
$482M
| $168K | ﹤0.01% |
+34,311
| New | +$173K |
|
2532
Horizon Bancorp
HBNC
$1.01B
| $168K | ﹤0.01% |
+10,404
| New | +$175K |
|
2533
Baytex Energy
BTE
$3.3B
| $166K | ﹤0.01% |
64,424
-12,046
| -16% | -$34.2K |
|
2534
Cogent Biosciences
COGT
$6.29B
| $162K | ﹤0.01% |
20,805
+1,687
| +9% | +$16.8K |
|
2535
eHealth
EHTH
$39.4M
| $161K | ﹤0.01% |
+17,125
| New | +$95.1K |
|
2536
Teekay
TK
$1.17B
| $161K | ﹤0.01% |
23,176
+4,620
| +25% | +$35.6K |
|
|
ATYR
2537
aTyr Pharma
ATYR
$52M
| $160K | ﹤0.01% |
+44,310
| New | +$134K |
|
2538
Kearny Financial
KRNY
$618M
| $160K | ﹤0.01% |
22,577
+3,914
| +21% | +$29.4K |
|
2539
GoPro
GPRO
$111M
| $159K | ﹤0.01% |
+146,120
| New | +$186K |
|
2540
Eton Pharmaceutcials
ETON
$1.84B
| $158K | ﹤0.01% |
+11,850
| New | +$120K |
|
2541
BRC Inc
BRCC
$133M
| $157K | ﹤0.01% |
+4,965
| New | +$155K |
|
2542
Manitowoc
MTW
$710M
| $156K | ﹤0.01% |
+17,140
| New | +$169K |
|
2543
C4 Therapeutics
CCCC
$504M
| $153K | ﹤0.01% |
42,533
+22,789
| +115% | +$113K |
|
2544
Lionsgate Studios
LION
$3.44B
| $153K | ﹤0.01% |
+20,100
| New | +$140K |
|
2545
Nerdy
NRDY
$87.7M
| $150K | ﹤0.01% |
+6,170
| New | +$115K |
|
|
PSTX
2546
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $149K | ﹤0.01% |
+15,562
| New | +$81.2K |
|
2547
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.04B
| $146K | ﹤0.01% |
11,254
| – | – |
|
2548
Cognyte Software
CGNT
$631M
| $145K | ﹤0.01% |
16,743
-125
| -0.7% | -$943 |
|
2549
Spectral AI Warrants
MDAIW
$6.24M
| $145K | ﹤0.01% |
190,324
| – | – |
|
2550
Kura Oncology
KURA
$1.1B
| $144K | ﹤0.01% |
16,485
-17,312
| -51% | -$249K |
|
Similar funds
Dmitry Balyasny's Q4 2024 Portfolio in Review
As of Q4 2024, Dmitry Balyasny held 3,413 positions worth $67.1B, up 9.5% from $61.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny deployed $4.68B of net new capital in Q4 2024, opening 750 new positions and adding to 913 existing holdings. Its largest new stake was Cisco: 4,075,610 shares worth $241M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Spotify, an estimated $314M trimmed.
- Dmitry Balyasny's largest Q4 2024 buy was Cisco: 4,075,610 shares worth $241M.
- Dmitry Balyasny added most to Amazon in Q4 2024, an estimated $655M increase.
- Dmitry Balyasny's biggest Q4 2024 reduction was Spotify, cutting an estimated $314M.
- Dmitry Balyasny fully exited CATALENT, INC. in Q4 2024, selling an estimated $220M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $67.1B portfolio in Q4 2024.
- Dmitry Balyasny opened 750 new positions and closed 747 in Q4 2024.
- Dmitry Balyasny's portfolio value rose 9.5% quarter-over-quarter to $67.1B.
Based on Balyasny Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.